![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: MPHOSPH6 |
Gene summary for MPHOSPH6 |
![]() |
Gene information | Species | Human | Gene symbol | MPHOSPH6 | Gene ID | 10200 |
Gene name | M-phase phosphoprotein 6 | |
Gene Alias | MPP | |
Cytomap | 16q23.3 | |
Gene Type | protein-coding | GO ID | GO:0000460 | UniProtAcc | Q99547 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
10200 | MPHOSPH6 | P127T-E | Human | Esophagus | ESCC | 2.75e-22 | 3.96e-01 | 0.0826 |
10200 | MPHOSPH6 | P128T-E | Human | Esophagus | ESCC | 1.63e-17 | 4.90e-01 | 0.1241 |
10200 | MPHOSPH6 | P130T-E | Human | Esophagus | ESCC | 8.93e-66 | 1.47e+00 | 0.1676 |
10200 | MPHOSPH6 | HCC1_Meng | Human | Liver | HCC | 7.71e-45 | 1.12e-02 | 0.0246 |
10200 | MPHOSPH6 | HCC2_Meng | Human | Liver | HCC | 1.41e-11 | 3.05e-02 | 0.0107 |
10200 | MPHOSPH6 | cirrhotic3 | Human | Liver | Cirrhotic | 2.63e-06 | 1.04e-01 | 0.0215 |
10200 | MPHOSPH6 | HCC1 | Human | Liver | HCC | 1.18e-02 | 2.04e+00 | 0.5336 |
10200 | MPHOSPH6 | HCC2 | Human | Liver | HCC | 4.53e-11 | 3.18e+00 | 0.5341 |
10200 | MPHOSPH6 | Pt13.b | Human | Liver | HCC | 2.14e-04 | 4.91e-02 | 0.0251 |
10200 | MPHOSPH6 | Pt14.a | Human | Liver | HCC | 1.24e-14 | 5.71e-01 | 0.0169 |
10200 | MPHOSPH6 | Pt14.b | Human | Liver | HCC | 2.26e-09 | 3.62e-01 | 0.018 |
10200 | MPHOSPH6 | Pt14.d | Human | Liver | HCC | 1.08e-02 | 2.52e-01 | 0.0143 |
10200 | MPHOSPH6 | S014 | Human | Liver | HCC | 3.13e-08 | 3.53e-01 | 0.2254 |
10200 | MPHOSPH6 | S015 | Human | Liver | HCC | 6.16e-08 | 3.75e-01 | 0.2375 |
10200 | MPHOSPH6 | S016 | Human | Liver | HCC | 1.34e-09 | 4.01e-01 | 0.2243 |
10200 | MPHOSPH6 | S028 | Human | Liver | HCC | 4.58e-08 | 3.59e-01 | 0.2503 |
10200 | MPHOSPH6 | S029 | Human | Liver | HCC | 2.73e-10 | 5.36e-01 | 0.2581 |
10200 | MPHOSPH6 | C04 | Human | Oral cavity | OSCC | 1.24e-52 | 2.51e+00 | 0.2633 |
10200 | MPHOSPH6 | C21 | Human | Oral cavity | OSCC | 1.39e-68 | 2.19e+00 | 0.2678 |
10200 | MPHOSPH6 | C30 | Human | Oral cavity | OSCC | 1.99e-33 | 1.50e+00 | 0.3055 |
Page: 1 2 3 4 5 6 7 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00226139 | Breast | Precancer | ribonucleoprotein complex biogenesis | 79/1080 | 463/18723 | 2.11e-18 | 1.03e-15 | 79 |
GO:00422549 | Breast | Precancer | ribosome biogenesis | 52/1080 | 299/18723 | 7.35e-13 | 1.51e-10 | 52 |
GO:00063646 | Breast | Precancer | rRNA processing | 35/1080 | 225/18723 | 7.90e-08 | 4.60e-06 | 35 |
GO:00160726 | Breast | Precancer | rRNA metabolic process | 36/1080 | 236/18723 | 8.59e-08 | 4.84e-06 | 36 |
GO:00344705 | Breast | Precancer | ncRNA processing | 42/1080 | 395/18723 | 9.91e-05 | 1.83e-03 | 42 |
GO:00346604 | Breast | Precancer | ncRNA metabolic process | 45/1080 | 485/18723 | 1.15e-03 | 1.26e-02 | 45 |
GO:002261314 | Breast | IDC | ribonucleoprotein complex biogenesis | 83/1434 | 463/18723 | 2.01e-13 | 5.20e-11 | 83 |
GO:004225414 | Breast | IDC | ribosome biogenesis | 52/1434 | 299/18723 | 1.90e-08 | 1.32e-06 | 52 |
GO:000636414 | Breast | IDC | rRNA processing | 35/1434 | 225/18723 | 4.59e-05 | 1.03e-03 | 35 |
GO:001607214 | Breast | IDC | rRNA metabolic process | 36/1434 | 236/18723 | 5.48e-05 | 1.17e-03 | 36 |
GO:002261324 | Breast | DCIS | ribonucleoprotein complex biogenesis | 83/1390 | 463/18723 | 3.65e-14 | 1.09e-11 | 83 |
GO:004225423 | Breast | DCIS | ribosome biogenesis | 52/1390 | 299/18723 | 6.73e-09 | 5.44e-07 | 52 |
GO:000636422 | Breast | DCIS | rRNA processing | 35/1390 | 225/18723 | 2.41e-05 | 5.62e-04 | 35 |
GO:001607222 | Breast | DCIS | rRNA metabolic process | 36/1390 | 236/18723 | 2.86e-05 | 6.42e-04 | 36 |
GO:003447011 | Breast | DCIS | ncRNA processing | 44/1390 | 395/18723 | 4.56e-03 | 3.49e-02 | 44 |
GO:002261327 | Esophagus | HGIN | ribonucleoprotein complex biogenesis | 158/2587 | 463/18723 | 2.61e-29 | 5.23e-26 | 158 |
GO:004225426 | Esophagus | HGIN | ribosome biogenesis | 101/2587 | 299/18723 | 8.74e-19 | 4.03e-16 | 101 |
GO:001607219 | Esophagus | HGIN | rRNA metabolic process | 72/2587 | 236/18723 | 2.26e-11 | 2.56e-09 | 72 |
GO:000636419 | Esophagus | HGIN | rRNA processing | 69/2587 | 225/18723 | 4.53e-11 | 5.04e-09 | 69 |
GO:003447010 | Esophagus | HGIN | ncRNA processing | 97/2587 | 395/18723 | 5.92e-09 | 3.90e-07 | 97 |
Page: 1 2 3 4 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa030186 | Breast | Precancer | RNA degradation | 14/684 | 79/8465 | 3.97e-03 | 2.37e-02 | 1.81e-02 | 14 |
hsa0301811 | Breast | Precancer | RNA degradation | 14/684 | 79/8465 | 3.97e-03 | 2.37e-02 | 1.81e-02 | 14 |
hsa0301821 | Breast | IDC | RNA degradation | 16/867 | 79/8465 | 5.65e-03 | 3.13e-02 | 2.34e-02 | 16 |
hsa0301831 | Breast | IDC | RNA degradation | 16/867 | 79/8465 | 5.65e-03 | 3.13e-02 | 2.34e-02 | 16 |
hsa030184 | Breast | DCIS | RNA degradation | 16/846 | 79/8465 | 4.45e-03 | 2.46e-02 | 1.82e-02 | 16 |
hsa030185 | Breast | DCIS | RNA degradation | 16/846 | 79/8465 | 4.45e-03 | 2.46e-02 | 1.82e-02 | 16 |
hsa0301810 | Esophagus | HGIN | RNA degradation | 27/1383 | 79/8465 | 7.73e-05 | 9.00e-04 | 7.15e-04 | 27 |
hsa0301815 | Esophagus | HGIN | RNA degradation | 27/1383 | 79/8465 | 7.73e-05 | 9.00e-04 | 7.15e-04 | 27 |
hsa0301824 | Esophagus | ESCC | RNA degradation | 62/4205 | 79/8465 | 1.18e-07 | 9.39e-07 | 4.81e-07 | 62 |
hsa0301834 | Esophagus | ESCC | RNA degradation | 62/4205 | 79/8465 | 1.18e-07 | 9.39e-07 | 4.81e-07 | 62 |
hsa03018 | Liver | Cirrhotic | RNA degradation | 44/2530 | 79/8465 | 1.43e-06 | 1.65e-05 | 1.02e-05 | 44 |
hsa030181 | Liver | Cirrhotic | RNA degradation | 44/2530 | 79/8465 | 1.43e-06 | 1.65e-05 | 1.02e-05 | 44 |
hsa030182 | Liver | HCC | RNA degradation | 58/4020 | 79/8465 | 2.29e-06 | 2.19e-05 | 1.22e-05 | 58 |
hsa030183 | Liver | HCC | RNA degradation | 58/4020 | 79/8465 | 2.29e-06 | 2.19e-05 | 1.22e-05 | 58 |
hsa030189 | Oral cavity | OSCC | RNA degradation | 59/3704 | 79/8465 | 2.05e-08 | 1.91e-07 | 9.70e-08 | 59 |
hsa0301814 | Oral cavity | OSCC | RNA degradation | 59/3704 | 79/8465 | 2.05e-08 | 1.91e-07 | 9.70e-08 | 59 |
hsa0301823 | Oral cavity | LP | RNA degradation | 39/2418 | 79/8465 | 6.98e-05 | 4.38e-04 | 2.83e-04 | 39 |
hsa0301833 | Oral cavity | LP | RNA degradation | 39/2418 | 79/8465 | 6.98e-05 | 4.38e-04 | 2.83e-04 | 39 |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
MPHOSPH6 | SNV | Missense_Mutation | novel | c.265C>T | p.Leu89Phe | p.L89F | Q99547 | protein_coding | tolerated(0.47) | benign(0.11) | TCGA-AN-A046-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
MPHOSPH6 | SNV | Missense_Mutation | novel | c.70N>A | p.Asp24Asn | p.D24N | Q99547 | protein_coding | deleterious(0.02) | probably_damaging(0.96) | TCGA-AR-A0U0-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
MPHOSPH6 | insertion | Nonsense_Mutation | novel | c.68_69insAAAATGCTCAACCTAAT | p.Asp24LysfsTer5 | p.D24Kfs*5 | Q99547 | protein_coding | TCGA-AR-A0U0-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | ||
MPHOSPH6 | SNV | Missense_Mutation | novel | c.33N>C | p.Lys11Asn | p.K11N | Q99547 | protein_coding | deleterious(0.01) | benign(0.119) | TCGA-C5-A7CK-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | SD |
MPHOSPH6 | SNV | Missense_Mutation | c.37C>A | p.Leu13Ile | p.L13I | Q99547 | protein_coding | tolerated(0.17) | possibly_damaging(0.566) | TCGA-CM-4752-01 | Colorectum | colon adenocarcinoma | Male | <65 | I/II | Unknown | Unknown | SD | |
MPHOSPH6 | SNV | Missense_Mutation | c.125N>T | p.Glu42Val | p.E42V | Q99547 | protein_coding | deleterious(0) | probably_damaging(0.979) | TCGA-G4-6309-01 | Colorectum | colon adenocarcinoma | Female | <65 | III/IV | Chemotherapy | xeloda | PD | |
MPHOSPH6 | SNV | Missense_Mutation | c.205G>T | p.Asp69Tyr | p.D69Y | Q99547 | protein_coding | deleterious(0.01) | probably_damaging(0.926) | TCGA-A5-A0G9-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
MPHOSPH6 | SNV | Missense_Mutation | c.283C>T | p.His95Tyr | p.H95Y | Q99547 | protein_coding | tolerated(0.34) | benign(0.001) | TCGA-AP-A051-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
MPHOSPH6 | SNV | Missense_Mutation | novel | c.434N>C | p.Asp145Ala | p.D145A | Q99547 | protein_coding | tolerated(0.11) | benign(0.01) | TCGA-AX-A2HC-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | paclitaxel | PD |
MPHOSPH6 | SNV | Missense_Mutation | novel | c.84G>T | p.Lys28Asn | p.K28N | Q99547 | protein_coding | deleterious(0) | possibly_damaging(0.857) | TCGA-E6-A1M0-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | carboplatin | SD |
Page: 1 2 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |